RXO
$13.6
Revenue | $1421Mn |
Net Profits | $-14Mn |
Net Profit Margins | -0.99% |
Rxo Inc’s revenue jumped 36.63% since last year same period to $1421Mn in the Q3 2025. On a quarterly growth basis, Rxo Inc has generated 0.14% jump in its revenue since last 3-months.
Rxo Inc’s net profit jumped 94.24% since last year same period to $-14Mn in the Q3 2025. On a quarterly growth basis, Rxo Inc has generated -55.56% fall in its net profits since last 3-months.
Rxo Inc’s net profit margin jumped 95.78% since last year same period to -0.99% in the Q3 2025. On a quarterly growth basis, Rxo Inc has generated -55.34% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.02 |
EPS Estimate Current Year | -0.02 |
Rxo Inc’s earning per share (EPS) estimates for the current quarter stand at -0.02 - a -150% fall from last quarter’s estimates.
Rxo Inc’s earning per share (EPS) estimates for the current year stand at -0.02.
Earning Per Share (EPS) | 0.01 |
Rxo Inc’s earning per share (EPS) jumped 100.55% since last year same period to 0.01 in the Q3 2025. This indicates that the Rxo Inc has generated 100.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-07 | 0.03 | 0.04 | 33.33% |
2025-11-06 | 0.04 | 0.01 | -75% |
2025-05-07 | -0.02 | -0.03 | -50% |